Invest Buffalo Niagara (InBN)—the nonprofit, privately-funded economic development organization representing the eight counties of Western New York—announced that Polymer Medical will expand operations in Buffalo Niagara. The medical device company plans to create 15 new, skilled jobs and invest $1.5 million.
The medical device company will undertake injection molding and assembly services, producing critical drug- delivery systems, medical and pharmaceutical disposables, devices for homecare and orthopedics, specialty packaging and more.
“As part of our expansion, we’re adding new technology to record data from our machines and all the equipment in the cell for making each part; this industry-leading capability means we can continually analyze the production attributes--or product DNA--of every part we make, ensuring superior quality,” said Ben Harp, President, Polymer Medical. “We greatly appreciate Invest Buffalo Niagara’s effort on our behalf. Their support will help Polymer Medical become the choice partner for medical disposables and medical devices worldwide.”
Polymer Medical has purchased a facility at 168 Thorn Avenue, Orchard Park, NY 14217. The facility is 4,500 sq. ft. The company was awarded a hydropower allocation from the New York Power Authority through the Recharge NY program.
Tom Kucharski, President & CEO, Invest Buffalo Niagara said, “We are happy to have helped land this expansion in Buffalo Niagara. Polymer Medical and its book of business realizes the perfect intersection of Buffalo’s strengths in advanced manufacturing and life and health sciences.”
Invest Buffalo Niagara has helped nearly 150 manufacturing companies expand or relocate to Western New York, joining a cluster of over 1,600 employers. Today, manufacturing is the third-largest employer sector in the Buffalo Niagara economy. As for life sciences, Buffalo ranks fourth in America for the per-capita percentage of life sciences workers, and the sector accounts for a full 2% of all employment in Buffalo Niagara—higher than the national average of 1.6%. Two thirds of Buffalo’s $530 million angel and venture capital funding is dedicated to life and health sciences
InBN assisted the Polymer Medical team with project management, incentive coordination, utility assistance and logistics connections.